Rapid pace of progress in the fields of biotechnology, genetics, and genomics, molecular genetic profiling may soon become an integral tool for clinicians to guide individualized treatments and management of many medical conditions. Personalized medicine (also termed personalized genomics, genomic medicine, or precision medicine) refers to the application of patient-specific profiles, incorporating genetic and genomic data as well as clinical and environmental factors, to assess individual risks and tailor prevention and disease-management strategies.
Our foremost testing and personalized solutions include:
Dysbiosis- GUT Microbiome Test. For a variety of lifestyle-related reasons, the body’s internal biochemistry can be moved from a healthy, balanced state to a state that can lead to chronic disease. These chronic conditions include Alzheimer’s, Parkinson’s, ALS, and diabetes. Additionally, poor internal fitness may cause less severe but more common health issues, such as irritable bowel syndrome, acid reflux, and leaky gut.
Our two-way business model helps patients, practitioners, and is making a change for society, felt through:
- Improved medical decision-making
- Delivery of appropriate therapies that are tailored to a patient’s sequence variants or genotype rather than the general population
- Optimized disease prevention strategies, including lifestyle and behavioral modification, as well as pharmaco-prevention
- Reduced exposure to or avoidance of medications of lower efficacy
- Reduced exposure to medications that have the potential for greater toxicity, with resulting lower incidence of treatment-related complications
- Reduced healthcare costs
- Enhanced patient satisfaction with the treatment process, improved tolerance of therapy, and better compliance
We now offer a biomarker test to detect cancer in asymptomatic individuals. It meets a wider acceptance, as it could lead to early diagnosis; reduce the use of more aggressive, more toxic, more costly therapy; and potentially result in a greater number of individuals being cured of their disease.
- Prognostic and predictive factors to assist treatment of non-metastatic breast cancer
- Markers to make an informed choice for Adjuvant chemotherapy for resected stage II colon cancer or
- Adjuvant therapy for resected stage III (node-positive) colon cancer through evaluation of Molecular markers and genomic profiling, and
- Systemic therapy in resectable non-small cell lung cancer through our Predictive biomarkers testing.
Genetic testing has focused on three types of genetic variation: (i) relatively rare, disease-causing sequence variants (mutations) that have a large effect on gene function and that are associated with Mendelian diseases (eg, conditions with autosomal dominant, autosomal recessive, and X-linked inheritance patterns); (ii) more common variants, often single nucleotide polymorphisms (SNPs) that are associated with an increased risk of complex diseases (eg, conditions in which the etiology is multifactorial in terms of more than one gene involved or gene-environment interactions); these SNPs commonly have smaller effects on gene function (iii) and sequence variants, often SNPs, that modulate drug response (pharmacogenetic variants). We harness the power of technology to:
Nutrition:
Nutrition and Diets have long supported the needs for a better and efficient recovery besides its need in a changing world full of foods that harm and environment that makes us more conducive to catch up chronic diseases and lifestyle disorders.
Cancer therapy in particular leaves a patient immunocompromised and exposed to toxicity of therapies that leave survivors at the helm of affairs and just about prayer to cope up with the diminishing health and chances of falling prey to the likely cure itself.
Green medications and supplements and traditional medicine by far offer a great promise to support or prevent diseases like cancer but sadly lack the required understanding of the biochemical pathways and aspects that helps a commixture to work.
Our in-depth knowledge and resource of over 45000 abstracts/publications, greater than 6000 evidence based healthcare articles covering over 10,000 health conditions is the largest global database that helps us recommend and support nutritional support for chronic diseases.
Cancer Survivors in particular need dedicated and personalized nutritional support during therapy and in post therapy and surveillance period to remain cancer free and fight away the side effects of medications. Our revolutionary and validated products, offerings to such critical needs are no match to any online or general supplements types available, more so as our clinician and scientist help you gain the insights and help you with personal opinion to back your needs that not only suit you but also help you consult an appropriate nutrition expert across the specialist we have on our panel.
Food-derived bioactive peptides represent health-enhancing components that play a regulatory function in the human body beyond their normal basic nutritional effects. Our products are based on International Compliances such as FDA and Green Regulatory for:
- Cancer Nutrition
- Brain Health
- Healthy Ageing
- Brain Health